TMSi

TMSi specializes in multiple physiological signal amplifiers, which are designed to capture and process biological signals like EEG (electroencephalography), ECG (electrocardiography), EMG (electromyography), and other physiological data. These devices are built for research and clinical use, enabling high-precision, low-noise simultaneous recording of multiple signals.

TMSi is based in the United States. Its devices are developed and marketed within the U.S. regulatory framework, adhering to FDA compliance requirements for medical devices.

Yes, TMSi’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for Class II devices, which are subject to stricter controls due to their moderate risk levels.

TMSi’s devices fall under FDA Class II classification. This classification is assigned based on the device’s intended use and risk level—Class II devices require special controls in addition to general controls to ensure safety and effectiveness, such as performance standards or post-market surveillance.